Long-term use of proton pump inhibitors - Really harmless?;Langzeit-Therapie mit Protonenpumpenhemmern: Wirklich unbedenklich?

Deutsche Medizinische Wochenschrift

Volumn 138, Issue 45, 2013, Pages 2319-2321

  Haag, S ^a  

^a Gastro Praxis Wiesbaden   (Germany)

Author keywords

adverse events; gastritis; GERD; PPI

Indexed keywords

PROTON PUMP INHIBITOR;

DRUG SAFETY; DRUG USE; LONG TERM CARE; NOTE;

ANTI-ULCER AGENTS; FRACTURES, BONE; HUMANS; NEOPLASMS; PNEUMONIA; PROTON PUMP INHIBITORS; RISK FACTORS;

EID: 84886661565     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0033-1349562     Document Type: Note

References (23)

1. Dublin S., Walker R. L., Jackson M. L. et al. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study. Pharmacoepidemiol Drug Saf: 2010; 19 792 802
2. den Elzen W. P., Groeneveld Y., de Ruijter W. et al. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment Pharmacol Ther: 2008; 27 491 497 (Pubitemid 351300856)
3. Eom C. S., Jeon C. Y., Lim J. W. et al. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ: 2011; 183 310 319
4. Gray S. L., LaCroix A. Z., Larson J. et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med: 2010; 170 765 771
5. Gulmez S. E., Holm A., Frederiksen H. et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med: 2007; 167 950 955 (Pubitemid 46762758)
6. Haag S., Andrews J. M., Katelaris P. H. et al. Management of Reflux Symptoms with Over-the-Counter Proton Pump Inhibitors: Issues and Proposed Guidelines. Digestion: 2009; 80 226 234
7. Hess M. W., Hoenderop J. G., Bindels R. J. et al. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther: 2012; 36 405 413
8. Hutchinson C., Geissler C. A., Powell J. J. et al. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut: 2007; 56 1291 1295 (Pubitemid 47300432)
9. Juul-Hansen P., Rydning A. Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy - negative reflux disease: is rebound hypersecretion of acid a problem? Scand J Gastroenterol: 2011; 46 398 405
10. Khalili H., Huang E. S., Jacobson B. C. et al. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ: 2012; 344 e372
11. Kwok C. S., Arthur A. K., Anibueze C. I. et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol: 2012; 107 1011 1019
12. Laheij R. J., Sturkenboom M. C., Hassing R. J. et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA: 2004; 292 1955 1960 (Pubitemid 39411203)
13. Leonard J., Marshall J. K., Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol: 2007; 102 2047 2056 (Pubitemid 47301504)
14. Lodrup A. B., Reimer C., Bytzer P. Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment. Scand J Gastroenterol: 2013; 48 515 522
15. Lundell L., Havu N., Miettinen P. et al. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol Ther: 2006; 23 639 647
16. Ness-Jensen E., Lindam A., Lagergren J. et al. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut: 2012; 61 1390 1397
17. Ngamruengphong S., Leontiadis G. I., Radhi S. et al. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Am J Gastroenterol: 2011; 106 1209 1218
18. Poulsen A. H., Christensen S., McLaughlin J. K. et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer: 2009; 100 1503 1507
19. Robertson D. J., Larsson H., Friis S. et al. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology: 2007; 133 755 760 (Pubitemid 47385871)
20. Sarkar M., Hennessy S., Yang Y. X. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med: 2008; 149 391 398
21. Sarzynski E., Puttarajappa C., Xie Y. et al. Association between proton pump inhibitor use and anemia: a retrospective cohort study. Dig Dis Sci: 2011; 56 2349 2353
22. Van Soest E. M., van Rossum L. G., Dieleman J. P. et al. Proton pump inhibitors and the risk of colorectal cancer. Am J Gastroenterol: 2008; 103 966 973 (Pubitemid 351501082)
23. Targownik L. E., Leslie W. D., Davison K. S. et al. The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). Am J Gastroenterol: 2012; 107 1361 1369